Numelvi® (atinvicitinib tablets) is an oral prescription medication used
to control pruritus associated with allergic dermatitis in dogs 6 months
of age and older. It targets the underlying itch and inflammation
pathways to provide effective relief while supporting simple, consistent
treatment routines. This therapy helps improve comfort and quality of
life for dogs affected by allergic skin conditions.

▪Second-generation JAK inhibitor designed for targeted itch control
▪Highly selective for JAK1, the primary driver of itch and inflammation
▪Onset of itch relief within 2 to 4 hours
▪Demonstrated significant improvement in itch within one week in
clinical studies
▪Once-daily oral dosing suitable for dogs 6 months and older weighing at
least 2 kg